About this trial

The goal of this national mutlticenter observational study is to learn and describe trends over time in the use of techniques for inducing hepatic hypertrophy in Italy. Patients will be treated according to the current clinical practice of the participating centers and will be observed from the moment of recruitment and throughout their stay. Information on vital status will be collected, as far as possible, for up to 5 years after surgery in order to record any events that occur in a timely manner. There are also plans to retrospectively collect data on patients who underwent hypertrophic techniques in the previous 10 years, in order to establish a historical cohort for each center that can be used for comparison with the prospective cohort.

Eligibility criteria

Qualifiers

Patients aged 18 or older

Obtaining informed consent

Patients with liver neoplasia (benign or malignant) and with a future liver remnant volume deemed insufficient (<20%-40%) by the local multidisciplinary team

Disqualifiers

pregnant or breastfeeding woman

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

2,000 Participants
are grouped into 2 trial groups

Locations

1
IRCCS Azienda Ospedaliero-Universitario di Bologna401328, BolognaBologna, Italy

Sponsors and collaborators

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Lead sponsor